ReviewHematology. American Society of Hematology. Education Program2014

Treatment of relapsed classical Hodgkin lymphoma in the brentuximab vedotin era.

Solomon A Graf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.